Biocryst Pharmaceuticals buy Needham & Company LLC
Start price
06.11.23
/
50%
€5.70
Target price
06.11.24
€11.17
Performance (%)
19.72%
Price
24.07.24
€6.82
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL currently has a performance of 19.72%. This prediction currently runs until 06.11.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biocryst Pharmaceuticals | -2.459% | -2.459% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Needham___Company_LL for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.98
07.05.24
07.05.24
€11.13
07.05.25
07.05.25
37.06%
24.07.24
24.07.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.00
08.01.24
08.01.24
€10.95
08.01.25
08.01.25
13.73%
24.07.24
24.07.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.47
03.08.23
03.08.23
€10.96
03.08.24
03.08.24
5.54%
24.07.24
24.07.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€12.77
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24